. . . . . "Vilanterol" . . . "ELLIPTA" . . . "Fluticasone Furoate" . . . "emphysema" . . . "acute bronchospasm" . . . "airflow obstruction" . "chronic obstructive pulmonary disease" . . . "chronic bronchitis" . . . "COPD" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "2022-10-10T15:19:49.777614"^^ . . " Fluticasone Furoate/Vilanterol ELLIPTA 100/25 mcg is indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. The drug is NOT indicated for relief of acute bronchospasm." . "2.3.0" . "RSA" . "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB" . "WdDi1hc8oywbfDoJPAckQbicxZxTx/PYCbxLg3O3AIB7uI8KMqErrKECwTCbx1RHtMkgC0vXTbYqunb2Vu9Qs99+OAl+wa09pgC9yMFRKpl77LyhLuaE6lxjUwQKbqauRtNgRpLOCLH8N+apMgzkd7m5KUb1hQj5IIhidCCTI4rD/amxQ8HgF7hCUX2sFiwvTmwKohp4js62+zH875mRvKYeFHzF8qod6h/w+lXbLD5I+zc9ErSTQPnm4YhqCVtg32OF0jgAk5CEPLbdGxcNAyDSZ9YASPgSggMkOD/lt0bgLMIBtsSkKn/lOoeP0ojcZ+47xCxv5YNBKwgMe5JnJw==" . . "2022-10-10T15:19:49.777614"^^ . .